{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Antineoplastic Biological Agent" in comments (approximate match)
Status:
Investigational
Source:
NCT04219254: Phase 1/Phase 2 Interventional Recruiting Solid Tumor, Adult
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT00606645: Phase 1 Interventional Completed Hodgkin Lymphoma
(2007)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02286219: Phase 1 Interventional Completed Solid Tumors That Overexpress HER2 (HER2 Positive)
(2014)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02754141: Phase 1/Phase 2 Interventional Completed Malignant Solid Tumor
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02837991: Phase 1 Interventional Terminated Renal Cell Carcinoma (RCC)
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03094169: Phase 1/Phase 2 Interventional Terminated Solid Tumor, Adult
(2017)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01891669: Phase 1 Interventional Terminated Neoplasms
(2013)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02674763: Phase 1 Interventional Completed Acute Myeloid Leukemia
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02529553: Phase 1 Interventional Completed Advanced Cancer
(2015)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01577745: Phase 1 Interventional Completed Solid Tumors
(2012)
Source URL:
Class:
CONCEPT